Clinical and research tests for C0476089 - Genetic Testing Registry (GTR) - NCBI

Warning: The NCBI web site requires JavaScript to function. more...

Results: 1 to 18 of 18

Tests names and labs	Conditions	Genes, analytes, and microbes	Methods
Hereditary Cancer Panel Comprehensive Molecular Genetics Laboratory London Health Sciences Centre Canada	39	30	D Deletion/duplication analysis C Sequence analysis of the entire coding region T Targeted variant analysis
KRAS Mutation Analysis PathGroup United States	13	1	T Targeted variant analysis
Hereditary Colon and Endometrial Cancer-ColoNGS GeneKor MSA Greece	10	7	D Deletion/duplication analysis C Sequence analysis of the entire coding region T Targeted variant analysis
Hereditary Non-Polyposis Colorectal Cancer (HNPCC) or Lynch Syndrome GeneKor MSA Greece	7	5	D Deletion/duplication analysis C Sequence analysis of the entire coding region T Targeted variant analysis
Inherited Bone Marrow Failure Panel PreventionGenetics United States	268	187	D Deletion/duplication analysis C Sequence analysis of the entire coding region T Targeted variant analysis
SmartGenomics GYN Profile with Microsatellite Instability Analysis PathGroup United States	6	52	I Microsatellite instability testing (MSI) T Targeted variant analysis
KRAS, BRAF, and NRA Mutation Analysis PathGroup United States	23	3	T Targeted variant analysis
KRAS, BRAF, NRAS and MSI Mutation Analysis PathGroup United States	23	3	T Targeted variant analysis
BRAF, EGFR, KRAS Mutation Analysis PathGroup United States	25	3	T Targeted variant analysis
PrimBio Cancer HotSpot Panel PrimBio Research Institute United States	60	50	T Targeted variant analysis
Hereditary Breast and Ovarian Cancer - Expanded and Lynch Syndrome Panel PreventionGenetics United States	29	33	D Deletion/duplication analysis C Sequence analysis of the entire coding region T Targeted variant analysis
Hereditary Breast and Ovarian Cancer - High Risk and Lynch Syndrome Panel PreventionGenetics United States	19	17	D Deletion/duplication analysis C Sequence analysis of the entire coding region T Targeted variant analysis
Hereditary Endometrial Cancer Panel PreventionGenetics United States	17	12	D Deletion/duplication analysis C Sequence analysis of the entire coding region T Targeted variant analysis
Hereditary Ovarian Cancer Panel PreventionGenetics United States	40	30	D Deletion/duplication analysis C Sequence analysis of the entire coding region T Targeted variant analysis
Lynch Syndrome Panel PreventionGenetics United States	8	5	D Deletion/duplication analysis C Sequence analysis of the entire coding region T Targeted variant analysis
PTEN Sequence Analysis (Prenatal Diagnosis) Baylor Genetics United States	8	1	T Targeted variant analysis
PTEN Sequence Analysis (Familial Mutation/Variant Analysis) Baylor Genetics United States	8	1	T Targeted variant analysis
myRisk Single Site Analysis Myriad Genetics, Inc. United States	32	45	T Targeted variant analysis

Results: 1 to 18 of 18

IMPORTANT NOTE: NIH does not independently verify information submitted to the GTR; it relies on submitters to provide information that is accurate and not misleading. NIH makes no endorsements of tests or laboratories listed in the GTR. GTR is not a substitute for medical advice. Patients and consumers with specific questions about a genetic test should contact a health care provider or a genetics professional.